Marinus Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch MRNS and buy or sell other stocks, ETFs, and their options commission-free!

About MRNS

Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the identification and development of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. 

CEO
Scott N. Braunstein
CEOScott N. Braunstein
Employees
40
Employees40
Headquarters
Radnor, Pennsylvania
HeadquartersRadnor, Pennsylvania
Founded
2003
Founded2003
Employees
40
Employees40

MRNS Key Statistics

Market cap
67.21M
Market cap67.21M
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
21.14M
Average volume21.14M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$4.07
52 Week high$4.07
52 Week low
$1.01
52 Week low$1.01
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.